Li Chu

4.6k total citations
189 papers, 3.5k citations indexed

About

Li Chu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li Chu has authored 189 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 43 papers in Oncology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Chu's work include Cardiac electrophysiology and arrhythmias (24 papers), Lung Cancer Treatments and Mutations (22 papers) and Traditional Chinese Medicine Analysis (20 papers). Li Chu is often cited by papers focused on Cardiac electrophysiology and arrhythmias (24 papers), Lung Cancer Treatments and Mutations (22 papers) and Traditional Chinese Medicine Analysis (20 papers). Li Chu collaborates with scholars based in China, Japan and United States. Li Chu's co-authors include Jianping Zhang, Xi Chu, Xuan Zhang, Xue Han, Zhihong Ma, Xue Han, Yucong Xue, Bin Zheng, Shengjiang Guan and Yonggang Gao and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Circulation Research.

In The Last Decade

Li Chu

184 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Chu China 33 1.4k 656 556 475 475 189 3.5k
Xiaoying Wang China 26 1.1k 0.8× 675 1.0× 201 0.4× 148 0.3× 527 1.1× 98 2.8k
Lianhong Yin China 46 2.7k 1.9× 317 0.5× 291 0.5× 410 0.9× 850 1.8× 118 5.3k
Hideki Mori Japan 36 1.7k 1.2× 424 0.6× 234 0.4× 548 1.2× 385 0.8× 190 4.3k
Yunman Li China 39 1.8k 1.3× 392 0.6× 195 0.4× 127 0.3× 382 0.8× 157 4.1k
Jianping Zhang China 28 852 0.6× 502 0.8× 161 0.3× 245 0.5× 301 0.6× 114 2.3k
Wei Deng China 40 3.0k 2.2× 614 0.9× 794 1.4× 1.4k 2.9× 240 0.5× 151 5.8k
Junping Kou China 40 2.9k 2.0× 188 0.3× 271 0.5× 330 0.7× 551 1.2× 175 5.2k
Weijun Peng China 35 1.6k 1.1× 227 0.3× 258 0.5× 155 0.3× 403 0.8× 105 3.2k
Heqing Huang China 35 1.7k 1.2× 246 0.4× 163 0.3× 193 0.4× 268 0.6× 92 3.5k

Countries citing papers authored by Li Chu

Since Specialization
Citations

This map shows the geographic impact of Li Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Chu more than expected).

Fields of papers citing papers by Li Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Chu. The network helps show where Li Chu may publish in the future.

Co-authorship network of co-authors of Li Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Chu. A scholar is included among the top collaborators of Li Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Chu. Li Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Li, Chenchen Chu, Mingyang Jiang, et al.. (2025). A photothermal-responsive multi-enzyme nanoprobe for ROS amplification and glutathione depletion to enhance ferroptosis. Biosensors and Bioelectronics. 278. 117384–117384. 4 indexed citations
2.
Chu, Li, et al.. (2025). Drug response is related to NR3C1 and FAAH polymorphism in Chinese pediatric epilepsy patients. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 51(1). 28–28.
3.
Ye, Luxi, Xiao Chu, Jianjiao Ni, et al.. (2024). NGS-based Tissue-Blood TMB Comparison and Blood-TMB Monitoring in Stage-III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Investigation. 42(2). 165–175. 1 indexed citations
4.
Lu, Jiachen, Li Chu, Qing‐Lin Chen, et al.. (2024). Profiles of visual perceptual learning in feature space. iScience. 27(3). 109128–109128.
5.
Yuan, Xun, Yue Zhou, Li Chu, et al.. (2023). The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study. Annals of Translational Medicine. 11(2). 60–60. 4 indexed citations
6.
Han, Xue, Panpan Liu, Bin Zheng, et al.. (2022). 6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-κB pathway in H9c2 cells. The Journal of Nutritional Biochemistry. 104. 108975–108975. 14 indexed citations
7.
Liu, Miaomiao, Bin Zheng, Panpan Liu, et al.. (2021). Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide‑induced acute liver injury. Molecular Medicine Reports. 23(6). 17 indexed citations
8.
Chen, Fangyu, Li Chu, Jie Li, et al.. (2020). Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells. Thoracic Cancer. 11(3). 570–580. 27 indexed citations
9.
Chu, Li, Jianjiao Ni, Xi Yang, et al.. (2019). Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities. Journal of Cancer. 10(26). 6660–6665. 3 indexed citations
10.
Xin, Ping, Shuning Liu, Ye Lu, et al.. (2019). Effects of Huazhuo Jiedu Shugan Decoction on Cognitive and Emotional Disorders in a Rat Model of Epilepsy: Possible Involvement of AC-cAMP-CREB Signaling and NPY Expression. Evidence-based Complementary and Alternative Medicine. 2019. 1–15. 12 indexed citations
11.
Hu, Wang, et al.. (2019). Plant leaf tooth feature extraction. PLoS ONE. 14(2). e0204714–e0204714. 8 indexed citations
12.
Li, Jun, Ran Duan, Yingying Zhang, et al.. (2018). Beta-adrenergic activation induces cardiac collapse by aggravating cardiomyocyte contractile dysfunction in bupivacaine intoxication. PLoS ONE. 13(10). e0203602–e0203602. 7 indexed citations
13.
Zhang, Jianping, Qiongtao Song, Xue Han, et al.. (2017). Multi-targeted protection of acetaminophen-induced hepatotoxicity in mice by tannic acid. International Immunopharmacology. 47. 95–105. 57 indexed citations
14.
Ma, Zhihong, Hongying Liu, Weijie Wang, et al.. (2017). Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells. Biomedicine & Pharmacotherapy. 90. 361–367. 27 indexed citations
15.
Chu, Li, Juemin Fang, Chunyan Li, et al.. (2015). The Traditional Chinese Medicinal Formula BDL301 Suppresses Tumor Growth by Inhibiting STAT3 Pathway and Inducing Apoptosis in Colorectal Cancer Cells. DNA and Cell Biology. 34(3). 178–188. 9 indexed citations
16.
17.
Wang, Na, Peng Guan, Jianping Zhang, et al.. (2011). Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA/ROCK pathway. Food and Chemical Toxicology. 49(11). 2975–2982. 29 indexed citations
18.
Chu, Li. (2010). Influence of centipede acidic protein on cardiomyocyte apoptosis induced by AngII. Journal of Beijing University of Traditional Chinese Medicine.
19.
Chu, Li. (2009). Tissue Culture and Rapid Propagation of Acanthopanax senticosus. Zhiwu yanjiu.
20.
Chu, Li. (2002). Involvement of Rho-kinase in regulation of contractility and cytosolic Ca^ induced by crosstalk of endothelin-1 and norepinephrine in canine myocardium. The Japanese Journal of Pharmacology. 88. 64. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026